Dr. J. Curtis Nickel is Professor of Urology at Queen's University in Kingston, Ontario, Canada. Dr. Curtis earned his medical degree from Queen’s University, and followed with an internship in surgery at Memorial University of Newfoundland. He completed his training with residencies in Urology and Surgery.
Dr. Nickel maintains a clinical research institute, the Centre for Applied Urological Research, at Queen’s University where he has received continuous peer-reviewed funding since 1985. Currently, he is funded by the US NIH and Canadian CIHR. His research is in the areas of inflammatory diseases (including infections), benign prostate hyperplasia (BPH) and pain diseases (prostatitis and interstitial cystitis) of the urinary tract. He has written more than 550 scientific papers, reviews, chapters and books on these topics.
His work within pain diseases has led to new awareness of these conditions, resulting in updated definitions and classifications, validated outcome parameters and recently, has initiated new diagnostic paradigms for this difficult field. He has been involved in multiple clinical trials (single and multicentre) in BPH, prostatitis and interstitial cystitis (frequently as one of the principal investigators) that have helped shape the evolution of medical therapy for these diseases.
He is the Editor of the AUA Update Series and is on the editorial board of eight national and international urology journals. He is also a regular reviewer for many urological and medical journals.
Dr. Nickle has been invited to present in over 35 universities in the United States and Canada, and at meetings or events in over 45 countries worldwide. In 2009 he was awarded the Distinguished Contribution Award from the American Urological Association for his research in Chronic Pelvic Pain in Men and Women and in 2015, the Societé d’Urologie Academy Award. He holds the prestigious Tier I Canadian Institutes of Health Research (CIHR) Canada Research Chair in Urologic Pain and Inflammation. He is currently Immediate Past President of the Canadian Urological Association.
Dr. Tadao Kakizoe is a retired urologic surgeon who formerly served as Director of the National Cancer Center (NCC) for ten years and previous to that role, was the 11th President for five years at the same institution. Dr. Kakizoe devoted his efforts to reducing the cancer incidence and mortality in Japan. Currently, he is serving as President of the Japan Cancer Society, working in close collaboration with the National Cancer Control Strategy (NCCS).
Dr. Kakizoe attended the University of Toronto, Ontario Cancer Institute (OCI) for one year and studied organic chemistry, searching for new mutagens and carcinogens in the urine of bladder cancer patients. He identified dibutylnitrosamine in the urine of diffuse carcinoma in situ patients.
He graduated from the University of Tokyo and was a member of the teaching staff within the Department of Urology for two years. He then joined the staff of the Urology Division, NCC Hospital where he remained for 32 years. During this time, he also worked in the Biochemistry Division of the NCC Research Institute, conducting research on bladder carcinogenesis and bladder cancer prevention with Dr Takashi Sugimura, now President Emeritus of NCC.
Dr. Kakizoe has accomplished a significant amount of work on bladder cancer from both clinical and basic viewpoints. He was awarded the NCC Tamiya Prize and Scientific Prize from the Princess Takamatsu Cancer Research Fund for his contributions.
He serves as Board Member Emeritus of the Japan Society of Clinical Oncology (JSCO) and the Japanese Cancer Association. He is a member of several Japanese governmental committees, including the Japanese Committee of the International Union against Cancer, and is on the board of the US-Japan Cancer Research Collaboration Program.
Dr. Kakizoe is Editor-in-Chief of Japanese Journal of Clinical Oncology. He has contributed more than 200 articles, in addition to several books and chapters, to scientific literature.
- UNITED KINGDOM
Prof. Anthony Mundy is a Consultant Urological Surgeon, Professor of Urology and Medical Director at University College London Hospitals (UCLH) NHS Foundation Trust. He trained in surgery and urology at Guy’s Hospital, London and joined the staff as Consultant Urologist in 1981. He continued as Professor of Urology in 1989 before joining the Institute of Urology and UCLH in 1995.
Prof. Mundy’s surgical practice is devoted to reconstructive urology, principally for the management of urethral stricture disease, iatrogenic trauma and complex urinary incontinence. In addition to complex urethral surgery, his current main activity is managing posterior urethral complications of the treatment of prostate and other pelvic cancers.
He has presented on 769 occasions to learned societies, has delivered a number of prestigious speeches and has been a visiting professor 47 times. He has written 203 original publications in peer-reviewed journals in addition to 65 chapters and 15 books. Prof. Mundy travels abroad widely to operate, with 144 occasions in the last 20 years.
Prof. Mundy is a past member of the Council of the Royal College of Surgeons of England, past President of the British Association of Urological Surgeons, past member of the Board of the European Association of Urology, and past President of the Genitourinary Reconstructive Surgeons. He is currently Honorary President of the European Association of Genitourinary Reconstructive Surgeons, President of the British Association of Genitourinary Reconstructive Surgeons and a founding member of the International Society for Reconstructive Urology.
Prof. Dr. Ying-Hao Sun currently serves as Vice President of the Chinese Medical Doctor Association and is the President of the Chinese Urological Association. Previously, he was a Major General in the People’s Liberation Army of China.
Prof. Sun received his medical degrees from First Military Medical University and Second Military Medical University in China. He completed his Fellowship at Johns Hopkins Hospital, in Maryland, USA and a residency in Urology at Changhai Hospital, in Shanghai, China.
Prof. Sun has been practicing urology for nearly 40 years with remarkable achievements in this field. His efforts and outstanding leadership in urology in Asia resulted in Chinese urologists collaborating with each other and with international colleges. As President of the 26th World Congress of Endourology, the 30th SIU Congress, and the 13th UAA Congress, he brought Chinese and international urologists together for the advancement of Chinese urology.
Prof. Sun initiated the charity campaign “Across Chinese Prostate-County” which provides medical aid to patients with urological conditions in rural areas, with a focus on prostate diseases. The goal of this campaign is to complete 10,000 operations and 1,883 have been performed as of May 2018. Prof. Sun also plans to promote this charity campaign in other countries in the future.
He has numerous medical patented devices. He is is the recipient of many prestigious awards including first prize in the National Science and Technology Advancement Award (2012), first prize in the Science and Technology Advancement Award of Shanghai (2012),and first prize in the Medical Science and Technology Award of Shanghai (2010). As a military doctor in the 2008 Wenchuan earthquake in China, for his efforts, he was awarded National Hero in Earthquake Relief by the Central Committee of the Communist Party of China (CPC), the State Council of China, and the Central Military Commission of the CPC.
Prof. Dr. Alain Le Duc is currently Professor of Urology at the University of Paris and a Urology teacher at the Faculty of Medicine Teilhard de Chardin, in N’Djamena, Chad. He was previously Dean of the Faculty of Medicine at Paris 7 University in Paris, France.
Past positions include Head of Department at St. Louis Hospital in Paris (1980–2005) where he focused on stone disease and kidney transplants. In 1982, he opened a pancreas transplant unit followed by an endourological and percutaneous unit in 1984. Dr. Le Duc was
an Assistant at Foch Hospital (1970–1980) working closely with Prof. Maurice Camey on radical cystectomy and bladder substitution and utilizing the Camey procedure and the Le Duc-Camey antireflux technique.
Prof. Le Duc is the recipient of several prestigious awards including the EAU Frans Debruyne Lifetime Achievement Award (2011), the SIU Distinguished Career Award (2009), the Karl Storz Endourology Award (2005), the EAU Willy Gregoir Medal (2003), and the EAU Scientific Prize for Medical Research on Laser Therapy for BPH (1978).
He is a member of several societies including Association Française d’Urologie (AFU), Société Internationale d'Urologie (SIU), and the European Association of Urology (EAU). He is a member of Académie Nationale de Chirurgie and past Chairman of the EAU Academy.
He is an International Consultant for the United Nations Population Fund (UNFPA) since 2008 and Co-chairman of Urology Speciality Courses, Medical Faculty at the University of Bamako in Mali. He is a member of Equilibre et Population, an organization committed to improving the living conditions and status of women and girls in West Africa, and Vice president of Chirurgie Solidaire, an association dedicated to providing surgical training in developing countries.
Additionally, Prof. Le Duc is an Administrative Council member of two NGOs that are involved in educating and training young surgeons in West Africa, focusing on urology and obstetric fistulas.